35 / 52
Page 117
Notes:
conferenceseries
.com
Volume 8, Issue 2 (Suppl)
Chem Sci J 2017
ISSN: 2150-3494 CSJ, an open access journal
Euro Chemistry 2017
May 11-13, 2017
May 11-13, 2017 Barcelona, Spain
4
th
European Chemistry Congress
Thanyathon Niyomthai et al., Chem Sci J 2017, 8:2(Suppl)
http://dx.doi.org/10.4172/2150-3494-C1-009Theoretical study: Non-small cell lung cancer drugs
Ulku Dilek Uysal
and
Halil Berber
Anadolu University, Turkey
A
fatinib, crizotinib and ceritinib (Figure 1) have been used as a treatment for non-small lung cancer in recent years [1]. To the
best of our knowledge; there has been no theoretical research about these three non-small cell lung cancer drugs in the literature.
The theoretical investigation of these molecules is an urgent need to understand the residance mechanism of these drug active
components.
Biography
Ulku Dilek Uysal has completed her PhD in 2001 from Gazi University and postdoctoral studies from Intitute of Chemical Technologies of Italian National Council
of Research (CNR). She is proffessor of Anadolu University at Chemistry Department. She has published more than 25 papers.
duysal@anadolu.edu.trN
N
N
O
N
O
N CH
3
CH
3
O
Cl
F
1af1
N
N
HN
O
N
OH
N CH
3
CH
3
O
Cl
F
N
N
N
O
N
O
N CH
3
CH
3
O
Cl
F
N
N
N
O
N
O
N CH
3
CH
3
O
Cl
F
1af2
1af4
H
1af3
N
N
N
O
N
OH
N CH
3
CH
3
O
Cl
F
1af2-1af4
N
N
N
O
N
OH
N CH
3
CH
3
O
Cl
F
1af2-1af3
K
T1
K
T2
K
T3
K
T5
K
T4
H
H
H
H
H
H
H
N
S O
O
N
N
Cl
N
O
N
H
N
S O
O
N
N
Cl
N
O
N
H
2ce1
2ce2
N
S O
O
N
N
Cl
N
O
N
H
2ce3
2ce5
N
S O
O
N
N
Cl
N
O
N
H
H
H
K
T2
H
H
2ce4
N
S O
O
N
N
Cl
N
O
N
H
H
H
H
H
H
H
K
T1
K
T3
K
T4
Cl
Cl
F
O
H H
3
C
N
NH
2
N N
HN
3cr1
Cl
Cl
F
O
H H
3
C
N
NH
N N
HN
3cr2
H
K
T1